BEIJING TIANTAN BIOLOGICAL PRODUCTS revenue breakdown overview

BEIJING TIANTAN BIOLOGICAL PRODUCTS revenue for the last year amounted to 6.03 B CNY, the most of which — 2.76 B CNY — came from its highest performing source at the moment, Intravenous Human Immunoglobulin. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING TIANTAN BIOLOGICAL PRODUCTS 6.01 B CNY, and the year before that — 5.16 B CNY.